Literature DB >> 26350609

Establishment of a novel human embryonic stem cell-derived trophoblastic spheroid implantation model.

Yin-Lau Lee1, Sze-Wan Fong2, Andy C H Chen2, Tiantian Li2, Chaomin Yue2, Cheuk-Lun Lee1, Ernest H Y Ng1, William S B Yeung1, Kai-Fai Lee3.   

Abstract

STUDY QUESTION: Can human embryonic stem cell-derived trophoblastic spheroids be used to study the early stages of implantation? SUMMARY ANSWER: We generated a novel human embryonic stem cell-derived trophoblastic spheroid model mimicking human blastocysts in the early stages of implantation. WHAT IS KNOWN ALREADY: Both human embryos and choriocarcinoma cell line derived spheroids can attach onto endometrial cells and are used as models to study the early stages of implantation. However, human embryos are limited and the use of cancer cell lines for spheroid generation remains sub-optimal for research. STUDY DESIGN, SIZE, DURATION: Experimental induced differentiation of human embryonic stem cells into trophoblast and characterization of the trophoblast. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Trophoblastic spheroids (BAP-EB) were generated by inducing differentiation of a human embryonic stem cell line, VAL3 cells with bone morphogenic factor-4, A83-01 (a TGF-β inhibitor), and PD173074 (a FGF receptor-3 inhibitor) after embryoid body formation. The expressions of trophoblastic markers and hCG levels were studied by real-time PCR and immunohistochemistry. BAP-EB attachment and invasion assays were performed on different cell lines and primary endometrial cells. MAIN RESULTS AND THE ROLE OF CHANCE: After 48 h of induced differentiation, the BAP-EB resembled early implanting human embryos in terms of size and morphology. The spheroids derived from embryonic stem cells (VAL3), but not from several other cell lines studied, possessed a blastocoel-like cavity. BAP-EB expressed several markers of trophectoderm of human blastocysts on Day 2 of induced differentiation. In the subsequent days of differentiation, the cells of the spheroids differentiated into trophoblast-like cells expressing trophoblastic markers, though at levels lower than that in the primary trophoblasts or in a choriocarcinoma cell line. On Day 3 of induced differentiation, BAP-EB selectively attached onto endometrial epithelial cells, but not other non-endometrial cell lines or an endometrial cell line that had lost its epithelial character. The attachment rates of BAP-EB was significantly higher on primary endometrial epithelial cells (EEC) taken from 7 days after hCG induction of ovulation (hCG+7 day) when compared with that from hCG+2 day. The spheroids also invaded through Ishikawa cells and the primary endometrial stromal cells in the co-culture. LIMITATIONS, REASONS FOR CAUTION: The attachment rates of BAP-EB were compared between EEC obtained from Day 2 and Day 7 of the gonadotrophin stimulated cycle, but not the natural cycles. WIDER IMPLICATIONS OF THE
FINDINGS: BAP-EB have the potential to be used as a test for predicting endometrial receptivity in IVF cycles and provide a novel approach to study early human implantation, trophoblastic cell differentiation and trophoblastic invasion into human endometrial cells.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  embryo development; human endometrium; implantation; in vitro implantation model; stem cells; trophoblasts

Mesh:

Year:  2015        PMID: 26350609     DOI: 10.1093/humrep/dev223

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  High-Throughput In Vitro Screening Identified Nemadipine as a Novel Suppressor of Embryo Implantation.

Authors:  Xian Chen; Sudini Ranshaya Fernando; Yin-Lau Lee; William Shu-Biu Yeung; Ernest Hung-Yu Ng; Raymond Hang-Wun Li; Kai-Fai Lee
Journal:  Int J Mol Sci       Date:  2022-05-03       Impact factor: 6.208

2.  Impaired function of trophoblast cells derived from translocated hESCs may explain pregnancy loss in women with balanced translocation (11;22).

Authors:  Alina Shpiz; Dalit Ben-Yosef; Yael Kalma
Journal:  J Assist Reprod Genet       Date:  2016-08-08       Impact factor: 3.412

Review 3.  Modeling human peri-implantation placental development and function†.

Authors:  J Zhou; R C West; E L Ehlers; T Ezashi; L C Schulz; R M Roberts; Y Yuan; D J Schust
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

4.  Deciphering transcriptional regulation in human embryonic stem cells specified towards a trophoblast fate.

Authors:  Ashish Jain; Toshihiko Ezashi; R Michael Roberts; Geetu Tuteja
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

5.  Transcriptomic Analysis of Naïve Human Embryonic Stem Cells Cultured in Three-Dimensional PEG Scaffolds.

Authors:  Christina McKee; Christina Brown; Shreeya Bakshi; Keegan Walker; Chhabi K Govind; G Rasul Chaudhry
Journal:  Biomolecules       Date:  2020-12-28

6.  Generation of Trophoblast-Like Cells From Hypomethylated Porcine Adult Dermal Fibroblasts.

Authors:  Sharon Arcuri; Georgia Pennarossa; Fulvio Gandolfi; Tiziana A L Brevini
Journal:  Front Vet Sci       Date:  2021-07-19

Review 7.  DNA Damage Response and Cell Cycle Regulation in Pluripotent Stem Cells.

Authors:  Andy Chun Hang Chen; Qian Peng; Sze Wan Fong; Kai Chuen Lee; William Shu Biu Yeung; Yin Lau Lee
Journal:  Genes (Basel)       Date:  2021-09-29       Impact factor: 4.096

Review 8.  Three-dimensional culture models of human endometrium for studying trophoblast-endometrium interaction during implantation.

Authors:  Xintong Li; Suranga P Kodithuwakku; Rachel W S Chan; William S B Yeung; Yuanqing Yao; Ernest H Y Ng; Philip C N Chiu; Cheuk-Lun Lee
Journal:  Reprod Biol Endocrinol       Date:  2022-08-13       Impact factor: 4.982

Review 9.  Organoids to model the endometrium: implantation and beyond.

Authors:  Thomas M Rawlings; Komal Makwana; Maria Tryfonos; Emma S Lucas
Journal:  Reprod Fertil       Date:  2021-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.